Sabcomeline Hydrochloride

N/A

Report date: 2022/05/18 12:02:12
NME

Base Information

Drug NameSabcomeline Hydrochloride
Drug Alias Namesabcomelinum盐酸沙可美林sabcomelina沙可美林盐酸盐沙可美林 +[12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M1 agonists
TargetsMuscarinic acetylcholine receptor M1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG